• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

持续的威胁。

: A Continuing Threat.

作者信息

Bhargava Ashish, Klamer Katherine, Sharma Mamta, Ortiz Daniel, Saravolatz Louis

机构信息

Thomas Mackey Center of Infectious Diseases, Henry Ford Health-St. John Hospital, Detroit, MI 48236, USA.

School of Medicine, Wayne State University, Detroit, MI 48202, USA.

出版信息

Microorganisms. 2025 Mar 13;13(3):652. doi: 10.3390/microorganisms13030652.

DOI:10.3390/microorganisms13030652
PMID:40142543
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11946832/
Abstract

is a World Health Organization critical-priority fungal pathogen that has variable resistance to antifungal treatments. Multiple clades have been identified through genomic analysis and have appeared in different geographic locations simultaneously. Due to a combination of factors including antifungal resistance, ability to colonize and persist in the environment, and thermotolerance, it can thrive. Infected patients are associated with a high mortality rate, especially those with multiple health risk factors like those associated with other species. This review highlights the current situation of this pathogen to help provide guidance for future work.

摘要

是一种世界卫生组织认定的关键优先真菌病原体,对抗真菌治疗具有不同程度的耐药性。通过基因组分析已鉴定出多个进化枝,且它们同时出现在不同地理位置。由于包括抗真菌耐药性、在环境中定殖和存活的能力以及耐热性等多种因素的综合作用,它能够大量繁殖。感染患者的死亡率很高,尤其是那些有多种健康风险因素的患者,就像感染其他物种相关病原体的患者一样。本综述强调了这种病原体的现状,以帮助为未来的工作提供指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b971/11946832/0cdb7e7a75ab/microorganisms-13-00652-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b971/11946832/0ba760f2f6d3/microorganisms-13-00652-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b971/11946832/0cdb7e7a75ab/microorganisms-13-00652-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b971/11946832/0ba760f2f6d3/microorganisms-13-00652-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b971/11946832/0cdb7e7a75ab/microorganisms-13-00652-g002.jpg

相似文献

1
: A Continuing Threat.持续的威胁。
Microorganisms. 2025 Mar 13;13(3):652. doi: 10.3390/microorganisms13030652.
2
Tracing the Evolutionary History and Global Expansion of Candida auris Using Population Genomic Analyses.利用群体基因组分析追踪耳念珠菌的进化历史和全球扩张。
mBio. 2020 Apr 28;11(2):e03364-19. doi: 10.1128/mBio.03364-19.
3
Independent introductions and nosocomial transmission of in Saudi Arabia ─ a genomic epidemiological study of an outbreak from a hospital in Riyadh.沙特阿拉伯的独立引入与医院内传播——利雅得一家医院疫情的基因组流行病学研究
Microbiol Spectr. 2025 Mar 4;13(3):e0326024. doi: 10.1128/spectrum.03260-24. Epub 2025 Feb 4.
4
Emergence of the novel sixth Clade VI in Bangladesh.孟加拉国新型第六 Clade VI 的出现。
Microbiol Spectr. 2024 Jul 2;12(7):e0354023. doi: 10.1128/spectrum.03540-23. Epub 2024 Jun 6.
5
The Gcn5 lysine acetyltransferase mediates cell wall remodeling, antifungal drug resistance, and virulence of .Gcn5赖氨酸乙酰转移酶介导细胞壁重塑、抗真菌药物抗性及(此处原文不完整,缺少具体对象)的毒力。
mSphere. 2025 Apr 29;10(4):e0006925. doi: 10.1128/msphere.00069-25. Epub 2025 Mar 11.
6
A decade after the emergence of Candida auris: what do we know?耳念珠菌出现十年后:我们了解多少?
Eur J Clin Microbiol Infect Dis. 2020 Sep;39(9):1617-1627. doi: 10.1007/s10096-020-03886-9. Epub 2020 Apr 15.
7
: Epidemiology and Antifungal Strategy.流行病学与抗真菌策略
Annu Rev Med. 2025 Jan;76(1):57-67. doi: 10.1146/annurev-med-061523-021233. Epub 2025 Jan 16.
8
Genomic epidemiology and antifungal-resistant characterization of , Colombia, 2016-2021.哥伦比亚 2016-2021 年的基因组流行病学和抗真菌耐药特征。
mSphere. 2024 Feb 28;9(2):e0057723. doi: 10.1128/msphere.00577-23. Epub 2024 Feb 1.
9
Global epidemiology of emerging Candida auris.新兴念珠菌全球流行病学。
Curr Opin Microbiol. 2019 Dec;52:84-89. doi: 10.1016/j.mib.2019.05.008. Epub 2019 Jul 3.
10
Genomic Diversity across Candida auris Clinical Isolates Shapes Rapid Development of Antifungal Resistance and .Candida auris 临床分离株的基因组多样性导致抗真菌药物耐药性的快速发展。
mBio. 2022 Aug 30;13(4):e0084222. doi: 10.1128/mbio.00842-22. Epub 2022 Jul 5.

引用本文的文献

1
Invasive Candidiasis in Contexts of Armed Conflict, High Violence, and Forced Displacement in Latin America and the Caribbean (2005-2025).拉丁美洲和加勒比地区武装冲突、高度暴力及被迫流离失所背景下的侵袭性念珠菌病(2005 - 2025年)
J Fungi (Basel). 2025 Aug 6;11(8):583. doi: 10.3390/jof11080583.
2
Innovative antifungal strategies to combat drug-resistant : recent advances and clinical implications.对抗耐药性的创新抗真菌策略:最新进展与临床意义
Front Cell Infect Microbiol. 2025 Jul 31;15:1641373. doi: 10.3389/fcimb.2025.1641373. eCollection 2025.
3
Chitosan-Based Hydrogels Containing Nystatin and Propolis as a Novel Tool for Skin Decolonization.

本文引用的文献

1
Recent increase in frequency in the SENTRY surveillance program: antifungal activity and genotypic characterization.SENTRY 监测项目中频率的近期增加:抗真菌活性和基因型特征。
Antimicrob Agents Chemother. 2024 Oct 8;68(10):e0057024. doi: 10.1128/aac.00570-24. Epub 2024 Sep 12.
2
Detection and characterisation of a sixth Candida auris clade in Singapore: a genomic and phenotypic study.在新加坡检测和表征第六个新型假丝酵母菌(Candida auris)菌株:一项基因组和表型研究。
Lancet Microbe. 2024 Sep;5(9):100878. doi: 10.1016/S2666-5247(24)00101-0. Epub 2024 Jul 13.
3
: A Systematic Review of a Globally Emerging Fungal Pathogen in Africa.
含有制霉菌素和蜂胶的壳聚糖基水凝胶作为皮肤去定植的新工具
Gels. 2025 Jun 26;11(7):498. doi: 10.3390/gels11070498.
4
Patterns and Predictors of Candidemia with Multidrug-Resistant Bacterial Co-Infections: Results from the CANDI-MDR Study.多重耐药菌合并感染的念珠菌血症模式及预测因素:CANDI-MDR研究结果
J Fungi (Basel). 2025 May 25;11(6):407. doi: 10.3390/jof11060407.
5
Early-Onset Candidemia in Adult Intensive Care Units.成人重症监护病房中的早发性念珠菌血症
Diagnostics (Basel). 2025 May 31;15(11):1402. doi: 10.3390/diagnostics15111402.
非洲一种全球新出现的真菌病原体的系统评价
Open Forum Infect Dis. 2023 Dec 27;11(6):ofad681. doi: 10.1093/ofid/ofad681. eCollection 2024 Jun.
4
The laboratory investigation, management, and infection prevention and control of : a narrative review to inform the 2024 national guidance update in England.实验室调查、管理以及感染预防和控制:一篇叙述性综述,旨在为 2024 年英格兰国家指南更新提供信息。
J Med Microbiol. 2024 May;73(5). doi: 10.1099/jmm.0.001820.
5
detected in the oral cavity of a dog in Kansas.在堪萨斯州的一只狗的口腔中检测到。
mBio. 2024 Feb 14;15(2):e0308023. doi: 10.1128/mbio.03080-23. Epub 2024 Jan 9.
6
Comparing the virulence of four major clades of Candida auris strains using a silkworm infection model: Clade IV isolates had higher virulence than the other clades.利用家蚕感染模型比较四种主要的耳念珠菌菌株的毒力:IV 型分离株比其他型具有更高的毒力。
Med Mycol. 2023 Nov 6;61(11). doi: 10.1093/mmy/myad108.
7
The rapid emergence of antifungal-resistant human-pathogenic fungi.抗真菌药物耐药性人类致病真菌的迅速出现。
Nat Rev Microbiol. 2023 Dec;21(12):818-832. doi: 10.1038/s41579-023-00960-9. Epub 2023 Aug 30.
8
Nationwide Outbreak of Candida auris Infections Driven by COVID-19 Hospitalizations, Israel, 2021-2022.2021-2022 年,因 COVID-19 住院而导致的以色列念珠菌感染的全国性爆发。
Emerg Infect Dis. 2023 Jul;29(7):1297-1301. doi: 10.3201/eid2907.221888.
9
Candida auris uses metabolic strategies to escape and kill macrophages while avoiding robust activation of the NLRP3 inflammasome response.耳念珠菌利用代谢策略来逃避和杀死巨噬细胞,同时避免 NLRP3 炎症小体反应的强烈激活。
Cell Rep. 2023 May 30;42(5):112522. doi: 10.1016/j.celrep.2023.112522. Epub 2023 May 18.
10
Heightened Efficacy of Anidulafungin When Used in Combination with Manogepix or 5-Flucytosine against Candida auris .阿尼芬净与马尼康唑或 5-氟胞嘧啶联合使用对耳念珠菌的增效作用。
Antimicrob Agents Chemother. 2023 Jun 15;67(6):e0164522. doi: 10.1128/aac.01645-22. Epub 2023 May 10.